Harmony Biosciences

+$0.49 (+1.18%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HRMY and other ETFs, options, and stocks.

About HRMY

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product WAKIX is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors.

CEO
John C.s Jacobs
Employees
150
Headquarters
Plymouth Meeting, Pennsylvania
Founded
2017

HRMY Key Statistics

Market Cap
2.39B
Price-Earnings Ratio
142.31
Dividend Yield
—
Average Volume
1.19M
High Today
$42.25
Low Today
$41.14
Open Price
$41.24
Volume
288.62K
52 Week High
$52.74
52 Week Low
$25.09

HRMY Earnings

-$0.14
$0.09
$0.31
$0.54
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
— per share
Actual
Available Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure